Digoxin Use in Atrial Fibrillation with Rapid Ventricular Rate and Severe Aortic Stenosis

Introduction to Rate Control

The European Society of Cardiology recommends that digoxin can be used cautiously in atrial fibrillation with rapid ventricular rate in the setting of severe aortic stenosis, but beta-blockers are strongly preferred as first-line therapy for rate control 1, 2

Beta-blockers should be the initial rate control agent in patients with atrial fibrillation, even in the presence of severe aortic stenosis, as they provide superior rate control during exercise and improved hemodynamic stability, according to the American Heart Association 3, 1
Beta-blockers are more effective than digoxin for controlling ventricular rate during physical activity, which is critical since digoxin's efficacy is reduced in states of high sympathetic tone, as noted by the American College of Cardiology 3, 4

Add digoxin if beta-blocker monotherapy fails to achieve adequate rate control, with a target resting heart rate <110 bpm initially, with consideration for <80 bpm at rest or <110-120 bpm during exercise, as recommended by the European Society of Cardiology 1, 2
Digoxin may be used as initial therapy if the patient has contraindications to beta-blockers or if there is coexisting left ventricular systolic dysfunction, according to the American Heart Association 1, 2

Avoid non-dihydropyridine calcium channel blockers in severe aortic stenosis due to their negative inotropic effects, which can precipitate hemodynamic collapse in patients dependent on preload and contractility, as warned by the European Society of Cardiology 1
Monitor closely for digoxin toxicity, as patients with severe aortic stenosis may have compromised renal perfusion, increasing risk of drug accumulation, according to the American College of Cardiology 2, 5

Start with digoxin 0.125 mg daily if the patient is elderly or has any degree of renal impairment, as recommended by the European Society of Cardiology 2

Check serial serum electrolytes and renal function, as digoxin causes arrhythmias particularly with hypokalemia, which can be catastrophic in aortic stenosis, according to the American Heart Association 2, 5
Target therapeutic serum digoxin concentration of 0.5-0.9 ng/mL, as recommended by the European Society of Cardiology 2

Do not use digoxin if the patient has second- or third-degree heart block without a permanent pacemaker, pre-excitation syndromes, or previous documented digoxin intolerance, as contraindicated by the American College of Cardiology 2, 4

Reduce digoxin dose by 50% if adding amiodarone, diltiazem, verapamil, certain antibiotics, or quinidine, as these agents significantly increase plasma digoxin levels, according to the European Society of Cardiology 2, 4

Digoxin as monotherapy is inadequate for acute rate control in rapid atrial fibrillation, as it takes 60 minutes to begin working and 6 hours for peak effect, making it unsuitable for urgent situations, as noted by the American Heart Association 3

Beta-blocker remains the cornerstone of long-term rate control in atrial fibrillation with aortic stenosis, according to the European Society of Cardiology 1, 4
Consider rhythm control strategies if rate control proves difficult, as maintaining sinus rhythm may provide better hemodynamic outcomes in severe aortic stenosis, as recommended by the American College of Cardiology 3